Growth Metrics

Thermo Fisher Scientific (TMO) Non-Current Deferred Tax Liability (2016 - 2025)

Thermo Fisher Scientific's Non-Current Deferred Tax Liability history spans 17 years, with the latest figure at $1.5 billion for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Deferred Tax Liability rose 17.74% year-over-year to $1.5 billion, compared with a TTM value of $1.5 billion through Dec 2025, up 17.74%, and an annual FY2025 reading of $1.5 billion, up 17.74% over the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 was $1.5 billion at Thermo Fisher Scientific, up from $842.0 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $3.8 billion in Q4 2021, with the low at $624.0 million in Q2 2025.
  • Average Non-Current Deferred Tax Liability over 5 years is $2.1 billion, with a median of $1.8 billion recorded in 2021.
  • Year-over-year, Non-Current Deferred Tax Liability soared 114.33% in 2022 and then plummeted 58.84% in 2025.
  • Tracing TMO's Non-Current Deferred Tax Liability over 5 years: stood at $3.8 billion in 2021, then fell by 25.75% to $2.8 billion in 2022, then crashed by 32.54% to $1.9 billion in 2023, then tumbled by 34.03% to $1.3 billion in 2024, then increased by 17.74% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Non-Current Deferred Tax Liability are $1.5 billion (Q4 2025), $842.0 million (Q3 2025), and $624.0 million (Q2 2025).